Buprenorphine analogs
US9175000B2 · kind B2 · utility
11Cited by
19References
47Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 4, 2013 |
| Grant date | Nov 3, 2015 |
| Priority date | — |
| Expiry date | Dec 4, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to Buprenorphine Analog compounds of the Formula I, Formula II, Formula III, Formula IV, and Formula V, wherein R1, R2, R3a, R3b, R15a, R15b, X, Q, G, and Y are as defined herein.Compounds of the Invention are useful for treating pain and other conditions modulated by activity of opioid receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.